Circular Solutions for Life Sciences

klaro is a digital waste and resource management solution that gives companies greater transparency over their waste streams, costs and recycling processes. By combining operational waste management with data analysis, invoice verification and optimisation, klaro helps organisations reduce waste, improve recycling and keep valuable materials in circulation.

Presented by: Göknur Bektas, Founder & Managing Director

Deasyl is a Swiss deep-tech company developing innovative, sustainable chemical processes that transform industrial by-products, such as crude glycerol, into high-value, bio-based chemicals. Through circular chemistry, Deasyl reduces waste and carbon emissions while providing sustainable alternatives for industries including cosmetics, personal care, and life sciences.

Presented by: Olivier Enos, CEO

GreenCheck Biotech AG replaces the plastic housings and components of conventional lateral flow rapid tests with a patented, cellulose-based design made from up to 97% renewable materials. This cuts fossil-based plastic in single-use diagnostics and enables shorter, local supply chains. As a drop-in, OEM-ready solution for point-of-care testing across diagnostic fields, it gives the life sciences sector a direct way to reduce plastic waste without changing existing assay workflows.

Presented by: Javier Sánchez, CEO

Beyond Diagnostics is developing LUMIQ, a point-of-use test that verifies whether temperature-sensitive biologic medicines such as insulin are still effective before use. By helping avoid the unnecessary disposal and replacement of medicines whose quality is uncertain, LUMIQ supports more circular use of high-value life-science products, reducing pharmaceutical waste, resource consumption, and unnecessary cold-chain losses.

Presented by: Dr. Maren Schinz, CEO & Founder

Elio makes ecodesign the default in pharma, starting with process chemistry. Built with large & small pharma companies, Elio is a process design workspace where sustainability is native: as chemists design routes and workup processes, they see the carbon impact of each choice alongside technical requirements, so sustainability is considered in every decision. Behind it runs a deterministic PCF engine covering hundreds of thousands of chemicals that common databases miss — fully traceable, not AI-invented.

Presented by: Kami Krista, Co-founder & CEO

Prevision Medicine helps oncologists identify the most effective treatments for their individual patients. This avoids unnecessary suffering and high costs associated with ineffective treatment rounds, but also allows identifying new applications for existing drugs through repurposing.

Presented by: Dr. Philip Zimmermann, CEO

Mycrobez AG uses fungal mycelium grown on agricultural residues to produce circular building materials, closing the loop from waste to product. The approach is rooted in life sciences, applying fungal biotechnology and cultivation processes to replace carbon-intensive construction materials with regenerative and highly functional alternatives.

Presented by: Moritz V Schiller, Founder and CEO